Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil for hypoxemia during gastroscopy sedation
ChiCTR2500106089Phase 4Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oliceridine in procedural pain, sponsored by Renji Hospital. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR2500106089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106089.